A higher risk of osteoporotic fracture was described in systemic sclerosis patients than in healthy patients.
Objective:
To evaluate the relation between osteoporotic fracture risk measured by the scanographic bone attenuation coefficient of the first lumbar vertebra (SBAC-L1) on computed tomography (CT) scan and the presence of ectopic calcifications: vascular, valvular and spinal.
Methods:
This monocentric retrospective study was performed on patients followed between 2000 and 2014 at Nancy University Hospital. Systemic sclerosis patients, according to ACR/EULAR 2013 criteria, followed from 2000 to 2014 and who underwent, during their follow-up, a CT including the first lumbar vertebra were included. The SBAC-L1 was measured with a threshold set at 145 Hounsfield units (HU). Vascular and spinal calcifications were studied on CT. For vascular calcifications, the Agatston score was used. Valvular calcifications were studied on echocardiography.
Results:
A total of 70 patients were included (mean age: 62.3 (±15.6) years, women 88.5%). The mean SBAC-L1 was 157.26 (±52.1) HU, and 35 patients (50%) presented an SBAC-L1 ⩽ 145 HU. The reproducibility of the calcification evaluation was good, with kappa coefficients varying between 0.63 and 1. In univariate analysis, spinal and vascular calcifications were associated with an SBAC-L1 ⩽ 145 HU, with ORs of 13.6 (1.6–113.3) and 8 (95%CI: 2.5–25.5), respectively. In multivariate analysis, the SBAC-L1 was not associated with the presence of any ectopic calcifications. The SBAC-L1 decreased with age (p = 0.0001).
Conclusion:
Patients with systemic sclerosis with an SBAC-L1 ⩽ 145 HU were older, but they did not have more ectopic calcification.
Trial registration:
The ethics committee of Nancy Hospital agreed with this study (referral file number 166). This study was designed in accordance with the general ethical principles outlined in the Declaration of Helsinki.
RichardsonCPlaasAVargaJ.Calcinosis in systemic sclerosis: updates in pathophysiology, evaluation, and treatment. Curr Rheumatol Rep2020; 22(10): 73.
2.
AuKSinghMKBodukamV, et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum2011; 63(7): 2078–2090.
3.
ColaciMSchinoccaCBoscoYD, et al. Heart valve abnormalities in systemic sclerosis patients: a multicenter cohort study and review of the literature. J Clin Rheumatol2022; 28(1): e95–e101.
4.
Scussel-LonzettiLJoyalFRaynauldJP, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine2002; 81(2): 154–167.
5.
AllanoreYAvouacJKahanA.Systemic sclerosis: an update in 2008. Joint Bone Spine2008; 75(6): 650–655.
TyndallAJBannertBVonkM, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis2010; 69(10): 1809–1815.
8.
AvouacJKoumakisETothE, et al. Increased risk of osteoporosis and fracture in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Arthritis Care Res2012; 64(12): 1871–1878.
9.
Ibn YacoubYAmineBLaatirisA, et al. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int2012; 32(10): 3143–3148.
10.
OmairMAPagnouxCMcDonald-BlumerH, et al. Low bone density in systemic sclerosis. A systematic review. J Rheumatol2013; 40(11): 1881–1890.
11.
MarotMValéryAEsteveE, et al. Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study. Oncotarget2015; 6(17): 14865–14873.
12.
OmairMAMcDonald-BlumerHJohnsonSR.Bone disease in systemic sclerosis: outcomes and associations. Clin Exp Rheumatol2014; 32(6 Suppl. 86): S28–S32.
13.
MokCCChanPTChanKL, et al. Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: a case-control study. Rheumatology2013; 52(2): 296–303.
14.
YuenSYRochwergBOuimetJ, et al. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol2008; 35(6): 1073–1078.
15.
SouzaRBCBorgesCTLTakayamaL, et al. Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol2006; 35(5): 384–387.
16.
FredianiBBaldiFFalsettiP, et al. Bone mineral density in patients with systemic sclerosis. Ann Rheum Dis2004; 63(3): 324–327.
17.
Di MunnoOMazzantiniMMasseiP, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol1995; 14(4): 407–412.
18.
CarboneLTylavskyFWanJ, et al. Bone mineral density in scleroderma. Rheumatology1999; 38(4): 371–372.
19.
Da SilvaHCSzejnfeldVLAssisLS, et al. Study of bone density in systemic scleroderma. Rev Assoc Med Bras1997; 43(1): 40–46.
20.
AtteritanoMSorbaraSBagnatoG, et al. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS ONE2013; 8(6): e66991.
21.
LoucksJPopeJE.Osteoporosis in scleroderma. Semin Arthritis Rheum2005; 34(4): 678–682.
22.
WanYNZhangLWangYJ, et al. The association between systemic sclerosis and bone mineral density: a meta-analysis of observational studies. Int J Rheum Dis2014; 17(8): 845–855.
23.
KilicGKilicEAkgulO, et al. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Int J Rheum Dis2016; 19(4): 405–411.
24.
FredianiBBaldiFFalsettiP, et al. Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheumatol2004; 22(3): 313–318.
25.
LaiCCWangSHChenWS, et al. Increased risk of osteoporotic fractures in patients with systemic sclerosis: a nationwide population-based study. Ann Rheum Dis2015; 74(7): 1347–1352.
26.
FaunyMBauerEAlbuissonE, et al. Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis. Rheumatol Int2018; 38(10): 1901–1910.
27.
DimaiHP.Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone2017; 104: 39–43.
28.
BassettLWBlockaKLFurstDE, et al. Skeletal findings in progressive systemic sclerosis (scleroderma). Am J Roentgenol1981; 136(6): 1121–1126.
29.
OgawaTOguraTHayashiN, et al. Tumoral calcinosis of thoracic spine associated with systemic sclerosis. J Rheumatol2009; 36(11): 2552–2553.
30.
WardMCuréJSchabelS, et al. Symptomatic spinal calcinosis in systemic sclerosis (scleroderma). Arthritis Rheum1997; 40(10): 1892–1895.
31.
DurantCFarge-BancelD.Clinical images: voluminous ectopic tumoral calcinosis of the spine in systemic sclerosis. Arthritis Rheum2011; 63(2): 411.
32.
WeerakoonASharpDChapmanJ, et al. Lumbar canal spinal stenosis due to axial skeletal calcinosis and heterotopic ossification in limited cutaneous systemic sclerosis: successful spinal decompression. Rheumatology2011; 50(11): 2144–2146.
33.
PickhardtPJPoolerBDLauderT, et al. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med2013; 158(8): 588–595.
34.
AgatstonASJanowitzWRHildnerFJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol1990; 15(4): 827–832.
35.
MoriSTakayaTKinugasaM, et al. Three-dimensional quantification and visualization of aortic calcification by multidetector-row computed tomography: a simple approach using a volume-rendering method. Atherosclerosis2015; 239(2): 622–628.
36.
MasseraDXuSBartzTM, et al. Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: the cardiovascular health study. Arch Osteoporos2017; 12(1): 52.
37.
Rodríguez-PalomaresJFEvangelista MasipA.Aortic calcium score and vascular atherosclerosis in asymptomatic individuals: beyond the coronary arteries. Rev Esp Cardiol2016; 69(9): 813–816.
38.
Van den HoogenFKhannaDFransenJ, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis2013; 72(11): 1747–1755.
39.
ErreGLMarongiuAFenuP, et al. The ‘sclerodermic hand’: a radiological and clinical study. Joint Bone Spine2008; 75(4): 426–431.
40.
GalièNHumbertMVachieryJL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J2016; 37: 67–119.
41.
CraiemDChironiGCasciaroME, et al. Calcifications of the thoracic aorta on extended non-contrast-enhanced cardiac CT. PLoS ONE2014; 9(10): e109584.
42.
GenantHKWuCYvan KuijkC, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res1993; 8(9): 1137–1148.
43.
Sampaio-BarrosPDCosta-PaivaLFilardiS, et al. Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheumatol2005; 23(2): 180–184.
44.
ValenzuelaABaronMHerrickAL, et al. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a scleroderma clinical trials consortium study. Semin Arthritis Rheum2016; 46(3): 344–349.
45.
ChanJJCupplesLAKielDP, et al. QCT volumetric bone mineral density and vascular and valvular calcification: the Framingham study. J Bone Miner Res2015; 30(10): 1767–1774.
46.
García-GómezMCVilahurG.Osteoporosis and vascular calcification: a shared scenario. Clin Investig Arterioscler2020; 32(1): 33–42.
47.
Krajewska-WłodarczykMStompórT.Osteoporosis and vascular calcification in rheumatoid arthritis – the role of osteoprotegerin and sclerostin. Pol Merkur Lekarski2017; 43(253): 41–47.
48.
LampropoulosCEKalamaraPKonstaM, et al. Osteoporosis and vascular calcification in postmenopausal women: a cross-sectional study. Climacteric2016; 19(3): 303–307.
49.
ZhangYFengB.Systematic review and meta-analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women. Int J Rheum Dis2017; 20(2): 154–160.
50.
FaunyMAlbuissonEBauerE, et al. Study of vertebral fracture and scanographic bone attenuation coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls. Sci Rep2019; 9(1): 13323.
